1 – 10 of 14
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Gain of chromosome 17 is an early genetic abnormality in neuroblastoma with PPM1D emerging as a strong candidate oncogene driving tumor progression
- Contribution to journal › Article
- 2024
-
Mark
Galectin-3 depletion tames pro-tumoural microglia and restrains cancer cells growth
- Contribution to journal › Article
- 2020
-
Mark
ASCL1 promotes tumor progression through cell-autonomous signaling and immune modulation in a subset of lung adenocarcinoma
- Contribution to journal › Article
-
Mark
Cysteinyl leukotriene receptor 1 promotes 5-fluorouracil resistance and resistance-derived stemness in colon cancer cells
- Contribution to journal › Article
- 2019
-
Mark
Modulation of lung cancer cell plasticity and heterogeneity with the restoration of cisplatin sensitivity by neurotensin antibody
- Contribution to journal › Article
- 2018
-
Mark
Montelukast, a CysLT1 receptor antagonist, reduces colon cancer stemness and tumor burden in a mouse xenograft model of human colon cancer
- Contribution to journal › Article
-
Mark
MiR-155-5p controls colon cancer cell migration via post-transcriptional regulation of Human Antigen R (HuR)
- Contribution to journal › Article
- 2017
-
Mark
MicroRNAs as cancer therapeutics : A step closer to clinical application
- Contribution to journal › Scientific review
-
Mark
Efficacy of the CDK inhibitor dinaciclib in vitro and in vivo in T-cell acute lymphoblastic leukemia
- Contribution to journal › Article
-
Mark
The dual specificity PI3K/mTOR inhibitor PKI-587 displays efficacy against T-cell acute lymphoblastic leukemia (T-ALL)
- Contribution to journal › Article
